Find News

Filter articles

Showing 91 to 100 of 3367 results

Sanofi and C4X in $493m licensing deal

EU13-04-2021Rory O'Neill

UK company C4X Discovery has agreed an exclusive licensing deal with Sanofi worth a potential €414 million, which will see the French pharmaceutical company develop anti-inflammatory therapies.

Brazil Supreme Court suspends drug patent extensions

Brazil08-04-2021Alex Baldwin

Brazil’s highest court has suspended extensions of drug patents due to the public health emergency caused by COVID-19.

UK govt’s £20m fund for life sciences opens for applications

UK08-04-2021Muireann Bolger

The UK government’s £20 million fund aimed at growing life sciences manufacturing is now open for applications, it confirmed today, April 7.

Moldex-Metric hits Honeywell with false advertising suit

International06-04-2021Alex Baldwin

Honeywell has been targeted in a recent complaint from competitor Moldex-Metric over a newly-launched “antimicrobial” earplug dispenser, which Moldex claims is falsely advertised.

AbbVie, Abbott fight bid to force FTC discovery disclosure

US06-04-2021Muireann Bolger

Pharmaceutical companies defending an antitrust lawsuit have fought back against attempts to get them to disclose confidential information garnered through discovery during the litigation to the US Federal Trade Commission.

PTAB invalidates Sanofi injector patent

France01-04-2021Alex Baldwin

Mylan Pharmaceuticals has succeeded in getting the Patent Trial and Appeal board (PTAB) to invalidate an injector patent held by French pharmaceutical company Sanofi

US govt doesn’t have remdesivir patent rights, says GAO

US01-04-2021Legal developmentsMuireann Bolger

The US government doesn't co-own patents covering Gilead Science’s drug remdesivir, according to a report by the Government Accountability Office.

Arthrex prevails in patent dispute over wrist fracture device

US30-03-2021Legal developmentsMuireann Bolger

In a win for medical device maker Arthrex, a federal judge in Delaware has ruled that its wrist-plating system does not infringe a patent owned by competitor TriMed Technologies.

Lundbeck loses €150m pay-for-delay appeal

EU30-03-2021Alex Baldwin

Lundbeck has lost an appeal to the Court of Justice of the European Union (CJEU) to waive €150 million ($176 million) in fines levied against itself and a group of five generics manufacturers over ‘pay-for-delay’ deals for its antidepressant generics.

WHO urges vigilance against fake COVID-19 vaccines

29-03-2021Rory O'Neill

The World Health Organization has warned the public of the danger of counterfeit COVID-19 vaccines and urged people not to procure jabs outside of government channels.

Showing 91 to 100 of 3367 results